ERNEXA THERAPEUTICS PRESENTS NEW PRECLINICAL DATA AT AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING ON LEAD CELL THERAPY CANDIDATE FOR TREATMENT OF OVARIAN CANCER

Reuters · 2d ago

Please log in to view news